Researchers at HEPIA, a part of the College of Utilized Sciences and Arts Western Switzerland (HES-SO) in Geneva, have developed and characterised a sequence of leaflet and valve implant prototypes aimed toward tackling the persistent scientific challenges of mitral valve restore in pediatric sufferers.
The examine evaluated 4 distinct biomaterials throughout structural, mechanical, and cell compatibility parameters.
Mitral valve prolapse (MVP) is the commonest indication for pediatric mitral valve surgical procedure. Regardless of this, the mortality charge for affected youngsters stays excessive — between 17.9% and 28.6% of sufferers don’t survive seven years post-surgery. Problems embody thromboembolism, immune rejection, calcification, and an infection, and the delicate anatomy of neonatal sufferers and restricted availability of appropriately sized prostheses additional complicate surgical intervention.
Tissue-engineered coronary heart valves (TEHVs) signify a bioengineering method supposed to deal with these gaps by supporting patient-specific anatomical match and in addition accommodating somatic progress.
4 supplies, two fabrication strategies
The analysis crew, led by Adrien Roux at HEPIA, produced 4 10-millimeter leaflet prototypes utilizing two manufacturing approaches. Leaflets one by means of three had been fabricated by way of standard laser slicing and freeze-drying processes utilizing ultrahigh-molecular-weight polyethylene (UHMWPE), UHMWPE coated with polyvinyl alcohol (PVA), and UHMWPE coated with PVA and kind I collagen. A fourth leaflet and a whole mitral valve implant prototype — designated ValCard — had been produced utilizing volumetric 3D bioprinting with gelatin methacrylate (GelMA) hydrogel.
The crew seeded all prototypes with mesoangioblasts remoted from the human fetal aorta (AoMAB), a stem cell subpopulation that shares phenotypic traits with the valvular interstitial cells present in native coronary heart tissue.
Cell viability exceeded 70% throughout all 4 supplies, with the GelMA leaflet recording the best end result at 216.77 ± 77.69%.
UHMWPE-PVA-collagen recognized as lead leaflet candidate
Among the many conventionally manufactured designs, the triple-layer UHMWPE-PVA-collagen leaflet posted the strongest general profile. It recorded a degradation charge of seven.30 ± 18.71% over 14 days, and probably the most secure cell proliferation sample over time. The PVA and collagen coatings had been discovered to switch the in any other case hydrophobic UHMWPE floor, introducing floor roughness that improved cell adhesion with out compromising the fabric’s mechanical properties.
GelMA-based constructs, whereas exhibiting superior cell viability and compatibility with volumetric 3D bioprinting for patient-specific geometries, had been excluded from degradation and traction testing as a result of mechanical limitations of a 2-millimeter-thick assemble.
The researchers famous that additional work is required earlier than scientific translation, together with permeability and thrombogenicity testing, in vivo validation in animal fashions, and formal characterization of the ValCard prototype below ISO cardiovascular implant requirements.